Aprofol AG is focused on bioactive (reduced) Folates. Local or systemic folate deficiencies have a strong influence on the progression of chronic diseases. Deep knowledge of the properties of the Folate forms makes the development of promising treatments for eye disease and autism (ASD) possible.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2013
  • Number of employees in Switzerland
    1-9